The efects oat beta-glucan consumption on the lipid profile of patients with hypercholesterolemia
DOI:
https://doi.org/10.62827/nb.v23i1.3008Keywords:
Beta-Glucans; hypercholesterolemia; avena.Abstract
Introduction: Oat beta-glucan has been highlighted for its lipid-lowering properties, being a potential nutritional intervention in controlling the lipid profile of these patients. Objective: To identify in national and international literature the effects of consuming oat beta-glucan on the lipid profile of patients with hypercholesterolemia. Methods: The Pubmed, Scielo and LILACS databases were searched for studies that demonstrated the effects of beta-glucan on lipid control in hypercholesterolemic patients from September to November 2022. Results: By applying pre-established search criteria with the terms “oats”, “cholesterol”, “beta-glucan” and “hypercholesterolemia”, 81 articles were found, from which 4 studies were selected covering the objectives for this integrative review. In summary, most studies have shown that supplementation with 3 g/day of oat beta-glucan has its medium-term effectiveness confirmed in reducing LDL-c and TC in hypercholesterolemic individuals, not indicating significant changes in HDL-c and triglycerides. Conclusion: The use of oat beta-glucan proved to be a diet therapy strategy that can help control lipids in hypercholesterolemic patients when associated with a healthy diet.
References
Silva DSMD, Assumpção DD, Francisco PMSB, Yassuda MS, Neri AL, & Borim FSA. Doenças crônicas não transmissíveis considerando determinantes sociodemográficos em coorte de idosos. Revista brasileira de geriatria e gerontologia. 2021;25: 210-204.
Izar MCDO, Giraldez VZR, Bertolami A, Santos FRDD, Lottenberg AM, Assad MHV, & Salgado F W. Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar–2021. Arquivos Brasileiros de Cardiologia. 2021; 117: 782-844.
IBGE Instituto Brasileiro de Geografia e Estatística. (2020). Pesquisa Nacional de Saúde: 2019: Percepção do Estado de Saúde, Estilos de Vida, Doenças Crônicas e Saúde Bucal: Brasil e Grandes Regiões.
Michel JM, Schreiber J A, Amon AB, Lauda BB, Teixeira GS, Barbato JPDR, & Bodanese LC. Tratamento atual da hipercolesterolemia e novas perspectivas. Acta méd. 2018; 65-71.
Ministério da Saúde. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose-2017. 2019.
Murphy EJ, Rezoagli E, Major I, Rowan NJ, & Laffey JG. β-glucan metabolic and immunomodulatory properties and potential for clinical application. Journal of Fungi. 2020;6 (4): 356.
Malanchen BE, Da Silva FA, Gottardi T, Terra DA, & Bernardi DM. Composição e propriedades fisiológicas e funcionais da aveia. Fag Journal of Health. 2019;1 (2): 185-200.
Henrion M, Francey C, Lê KA, Lamothe L. Cereal B-glucans: The impact of processing and how it affects physiological responses. Nutrients. 2019;11(8): 1729.
Beyea Sc, Nicoll Lh. Writing an integrative review. AORN J. 1998; 67(4): 877-80.
Yu J, Xia J, Yang C, Pan D, Xu D, Sun G, & Xia H. Effects of oat beta-glucan intake on lipid profiles in hypercholesterolemic adults: A systematic review and meta-analysis of randomized controlled trials. Nutrients. 2022;14(10): 2043.
Cicero AF, Fogacci F, Veronesi M, Strocchi E, Grandi E, Rizzoli E, & Borghi C. A randomized placebo-controlled clinical trial to evaluate the medium-term effects of oat fibers on human health: the beta-glucan effects on lipid profile, glycemia and intestinal health (BELT) study. Nutrients. 2020;12(3): 686.
Souza SR, De Oliveira GMM, Luiz RR, & Rosa G. Effects of oat bran and nutrition counseling on the lipid and glucose profile and anthropometric parameters of hypercholesterolemia patients. Nutrición Hospitalaria. 2016;33(1), 123-130.
Vizuete, A, & Ortega A R M. Efectos del consumo del beta-glucano de la avena sobre el colesterol sanguíneo: una revisión. Revista Española de Nutrición Humana y Dietética. 2016;20(2): 127-139.
Oliveira ECD, Barbosa GC, Corrente JE, Komuro JE, & Papini SJ. Farelo de aveia no controle de risco cardiovascular em transtorno mental. Revista Brasileira de Enfermagem. 2020; 73.
Grundy MM, Fardet A, Tosh SM, Rich GT, Wilde PJ. Processing of oat: The impact on oat’s cholesterol lowering effect. Food Funct. 2018;9: 1328–1343.
Wang Y, Harding SV, Eck P, Thandapilly SJ, Gamel TH, Abdel-Aal ESM, Crow GH, Tosh SM, Jones PJ, Ames NP. High-Molecular-Weight β-Glucan Decreases Serum Cholesterol Differentially Based on the CYP7A1 rs3808607 Polymorphism in Mildly Hypercholesterolemic Adults. J. Nutr. 2016;146: 720–727.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Salvina de Oliveira Lima, Macileide da Silva Bandeira, Nathália Bernardo Marinho, Lília Teixeira Eufrásio Leite, Helen Pinheiro, Anarah Suellen Queiroz Conserva Vitoriano, Andressa Eslayne Caldas Sales, Ana Carolina Cavalcante Viana (Autor)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution 4.0 que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
Autores têm autorização para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
